An interventional study of Topical Product: Almond Oil and Topical Product: Almond oil augmented with 0.5% Vitamin E in Collagen Degeneration, Wrinkle and Pigmentation, sponsored by Integrative Skin Science and Research. Recruiting at 1 site in United States. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-28.
Sponsored by Integrative Skin Science and Research · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 26 studies in Ehlers-Danlos Syndrome with a site in United States — 9 open to participants now, 11 under way, none of them phase 3. Ehlers-Danlos Syndrome · United States.
Among the 26 studies in Ehlers-Danlos Syndrome with a site in United States, this one is the 6th largest by planned enrollment of the 15 interventional ones that give a count, is one of 4 that started in 2024, is one of 13 with no phase, reaches primary completion later than 1 of the 10 other live ones, and was the 21st registered.
67 studies on the registry are indexed under Ehlers-Danlos Syndrome; 24 are open to participants now.
Browse Ehlers-Danlos Syndrome studies →9 of the 26 studies in Ehlers-Danlos Syndrome with a site in United States are open now. Recruiting first, the newest first:
Brigham and Women's Hospital · Sites in United States
Ages 18+
xCures · Sites in United States
Integrative Skin Science and Research · Sites in United States
Ages 35–70 · Women only · Healthy volunteers
Brain Inflammation Collaborative · Sites in United States
Ages 2+ · Healthy volunteers
New York Institute of Technology · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 12 Ehlers-Danlos Syndrome studies recruiting now, 9 (75%) set no upper age limit and 3 (25%) stop at 75 or younger; 4 take children under 18; 5 take healthy volunteers.
This study: 18 Years and older · female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
26 studies; the count open now beside each. This study's row is marked.
First in 1997; this study’s year is marked. 4 started in 2024.
This study's planned enrollment of 90 is above the median of 60 across 32 interventional studies indexed under Ehlers-Danlos Syndrome.
Median enrollment 60 across the 15 interventional studies, 334 across the 11 observational. Of the 15 that completed or were terminated, 2 (13%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 26 have an industry lead sponsor. The 10 most frequent:
Integrative Skin Science and Research is the lead sponsor of 35 studies on the registry; 12 are open to participants now.
Integrative Skin Science and Research has 2 studies filed under Ehlers-Danlos Syndrome — fewer than ten, so there is no comparison to draw.
2 of the studies in Ehlers-Danlos Syndrome with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07464093Brigham and Women's HospitalSTABLE Pilates for Hypermobility | 2026-12 |
| NCT07743229Medical University of South CarolinaCOG+OT Telerehabilitation for Adults With Subjective Cognitive Complaints | 2027-07-31 |
Add all 2 to your calendar (.ics) → With an account.
Among the 26 studies in Ehlers-Danlos Syndrome with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Investigate the topical use of almond oil, almond oil augmented with 0.5% vitamin E, 0.025% tretinoin oil augmented with castor oil on the appearance of facial fine lines and wrinkles, pigmentation, hydration, trans-epidermal water loss, and sebum excretion rate.
The natural cosmetic market is a multi-billion dollar industry. Nutraceuticals and food-based cosmetics are a growing trend within dermatology. Almonds are a rich dietary source of a range of fatty acids, phytochemical polyphenols, and antioxidants. Our previous study was a double blinded study that compared almond consumption interventions to a calorie matched intervention over 16 weeks. The study determined that that there was a statistically significant 8.41% improvement in wrinkle severity in the women that received almond supplementation. This proposal aims to now understand how the topical application of almond oil may influence the appearance of wrinkles and facial tone in post-menopausal women. Almond oil is rich in fatty acids and alpha-tocopherol. Tocopherol inhibits melanogenesis in melanocytes and topical alpha tocopherol has been shown to improve skin antioxidants and hyperpigmentation. A challenge of almond oil is that it is prone to oxidation due to its high unsaturated fatty acid concentrations. However, tocopherol has also been shown to improve almond oil stability.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
A planned gap after a treatment, so that its effects can lessen before the study treatment or a study assessment. Ask the study team and the doctor who prescribed it before changing any medicine.
Postmenopausal
Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Autoimmune disease
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Washout period
A planned gap after a treatment, so that its effects can lessen before the study treatment or a study assessment. Ask the study team and the doctor who prescribed it before changing any medicine.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Almond Oil. 1-2 Drops of randomized topical product will be applied on entire face nightly. Duration: 16 weeks
Other: Topical Product: Almond Oil
Almond oil augmented with 0.5% Vitamin E. 1-2 Drops of randomized topical product will be applied on entire face nightly. Duration: 16 weeks
Other: Topical Product: Almond oil augmented with 0.5% Vitamin E
0.025% Tretinoin oil augmented with castor oil. 1-2 Drops of randomized topical product will be applied on entire face nightly. Duration: 16 weeks
Other: Topical Product: 0.025% Tretinoin oil augmented with castor oil
1-2 Drops of randomized topical product will be applied on entire face nightly.
1-2 Drops of randomized topical product will be applied on entire face nightly.
1-2 Drops of randomized topical product will be applied on entire face nightly.
Facial wrinkles
Change in severity of wrinkles measured by photographic analysis (BTBP 3D Camera System)
Time frame: 16 Weeks
Changes in Pigment intensity through the use of high resolution photography (BTBP Clarity Pro)
Change in the appearance of facial pigmentation by high resolution photography (BTBP Clarity Pro) and measures intensity of facial pigmentation. Higher scores indicate darker pigmentation.
Time frame: 16 Weeks
Pigment intensity measured through SkinColorCatch.
Change in the appearance of facial pigmentation will be measured on both cheeks through the use of a handheld device known as the SkinColorCatch with quantitative output for pigment intensity.
Time frame: 16 Weeks
Changes in skin hydration
Change in skin hydration will be measured on both cheeks through the use of a non-invasive device known as the Moisturemeter.
Time frame: 16 Weeks
Sebum excretion rate
Measure of skin sebum via sebumeter
Time frame: 16 Weeks
Tolerability Assessment Questionnaire
A 6 question survey based on the self-assessment about the tolerability of the topical skin product. The scale ranges from 0-3 with 0 being the best outcome possible and with 3 being the worst. "0" as none, "1" as mild, "2" as moderate, or "3" as severe.
Time frame: 16 Weeks
Transepidermal water loss
Change in transepidermal water loss (TEWL) using the Vapometer
Time frame: 16 Weeks
Plan to share: No
No publications or documents are linked to this record.
Started Jul 2024 (actual). Primary completion is estimated for Jan 2025, 6 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Integrative Skin Science and Research →